Drug Profile
Research programme: kinase inhibitors - ocular diseases - MethylGene/Otsuka
Latest Information Update: 25 Jan 2024
Price :
$50
*
At a glance
- Originator MethylGene
- Class Small molecules
- Mechanism of Action Enzyme inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Suspended Eye disorders